Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 751 | 477 | 22 |
Full Text Views | 4 | 0 | 0 |
PDF Downloads | 3 | 0 | 0 |
Tinidazole, a recent derivative of the nitroimidazole group of compounds, was able to achieve a cure in 96% of children with acute amebic dysentery when given in three single daily doses of approximately 60 mg/kg of body weight. At a dose of approximately 50 mg/kg the cure rate was only 76%. The drug was well tolerated and completely free from any toxic effects. Tinidazole can confidently be recommended as a very simple and safe form of therapy for amebic dysentery.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 751 | 477 | 22 |
Full Text Views | 4 | 0 | 0 |
PDF Downloads | 3 | 0 | 0 |